Comments

Neurocrine Biosciences

Q: What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NBIXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$135.42

0.460.34%

At close: -

$135.42

0.000.00%

After Hours: Dec 20, 4:03 PM EDT

Neurocrine Biosciences (NBIX) Forecast

News Earnings Neurocrine Biosciences (NBIX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

Neurocrine Biosciences (NASDAQ:NBIX) Stock Quotes, Forecast and News Summary

Neurocrine Biosciences Stock (NASDAQ: NBIX) stock price, news, charts, stock research, profile.

Open	$134.98
Close	$135.42
Volume / Avg.	2.27M / 938.91K
Day Range	$134.12 - $137.01
52 Wk Range	110.95 - 157.98
Market Cap	$13.71B
P/E Ratio	35.99
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	4.52%
Days to Cover	3.78

Recent News

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

Neurocrine's Crenessity receives FDA approval as a groundbreaking adjunctive treatment for classic CAH, offering a novel approach to hormone regulation.

Vandana Singh

Screening For Black Friday Bargains In The Stock Market

David Pinsen

AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio

AbbVie stock drops after emraclidine fails Phase 2 trials for schizophrenia, raising questions about its neuroscience strategy and boosting competition for Cobenfy.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$134.98
Close	$135.42
Volume / Avg.	2.27M / 938.91K
Day Range	$134.12 - $137.01
52 Wk Range	110.95 - 157.98
Market Cap	$13.71B
P/E Ratio	35.99
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	4.52%
Days to Cover	3.78

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Neurocrine Biosciences (NBIX) stock?

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.

View our list of the best stock brokerages

Who are Neurocrine Biosciences (NBIX) competitors?

Other companies in Neurocrine Biosciences’s space includes: Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for Neurocrine Biosciences (NBIX) stock?

Neurocrine Biosciences has a consensus price target of $163.74.

What is the current price for Neurocrine Biosciences (NBIX)?

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $135.42 last updated December 20, 2024 at 4:03 PM EST.

Does Neurocrine Biosciences (NBIX) pay a dividend?

There are no upcoming dividends for Neurocrine Biosciences.

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

Neurocrine Biosciences’s Q4 earnings are confirmed for Wednesday, February 5, 2025.

Is Neurocrine Biosciences (NBIX) going to split?

There is no upcoming split for Neurocrine Biosciences.

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.